• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF

    10/23/25 6:46:00 AM ET
    $BLSH
    $DASH
    $FLY
    $IREN
    Finance: Consumer Services
    Finance
    EDP Services
    Technology
    Get the next $BLSH alert in real time by email

    Funds seek to provide 200% long exposure on a variety of industry leaders

    NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched nine new single stock leveraged ETFs, seven of which are first-to-market strategies. The funds, all listed on Cboe, seek to deliver twice (200%) the daily performance of a specific underlying stock.

    The following ETFs are first-to-market exposures:

    • Tradr 2X Long BLSH Daily ETF (Cboe: BLSX) – tracks Bullish Limited (NYSE:BLSH)
    • Tradr 2X Long DASH Daily ETF (Cboe: DASX) – tracks DoorDash, Inc. (NASDAQ:DASH)
    • Tradr 2X Long FLY Daily ETF (Cboe: FLYT) – tracks Firefly Aerospace, Inc. (NASDAQ:FLY)
    • Tradr 2X Long NEM Daily ETF (Cboe: NWMX) – tracks Newmont Corporation (NYSE:NEM)
    • Tradr 2X Long OPEN Daily ETF (Cboe: OPEX) – tracks Opendoor Technologies Inc. (NASDAQ:OPEN)
    • Tradr 2X Long SRPT Daily ETF (Cboe: SRPU) – tracks Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
    • Tradr 2X Long WULF Daily ETF (Cboe: WULX) – tracks TeraWulf, Inc. (NASDAQ:WULF)

    Today's launch also includes the following ETFs:

    • Tradr 2X Long IREN Daily ETF (Cboe: IREX) – tracks IREN Limited (NASDAQ:IREN)
    • Tradr 2X Long QS Daily ETF (Cboe: QSX) – tracks QuantumScape Corporation (NYSE:QS)

    "This is our largest set of single-stock ETF launches to date and covers several trailblazing stories across a swath of industries," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "In addition to electrifying AI-infrastructure plays like IREN and TeraWulf, we are introducing the industry's first single-stock ETF on a gold miner represented by Newmont, the world's largest gold company."

    In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia. With today's listings, Tradr's lineup has grown to 48 leveraged ETFs representing over $2 billion in assets under management. Tradr's strategies can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.

    For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.

    About Tradr ETFs

    Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.

    IMPORTANT RISK INFORMATION

    Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.

    Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.

    Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.

    The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.

    ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.

    ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

    Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.

    Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000768

    (PRNewsfoto/Tradr ETFs)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tradr-debuts-leveraged-etfs-on-blsh-dash-fly-iren-nem-open-qs-srpt--wulf-302591439.html

    SOURCE Tradr ETFs

    Get the next $BLSH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLSH
    $DASH
    $FLY
    $IREN

    CompanyDatePrice TargetRatingAnalyst
    Newmont Corporation
    $NEM
    2/27/2026$157.00Mkt Perform → Outperform
    Bernstein
    Newmont Corporation
    $NEM
    2/20/2026$145.00 → $140.00Outperform
    BMO Capital Markets
    QuantumScape Corporation
    $QS
    2/19/2026$8.30Reduce → Hold
    HSBC Securities
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    Sarepta Therapeutics Inc.
    $SRPT
    1/28/2026$20.00Equal Weight
    Barclays
    Bullish
    $BLSH
    1/15/2026$55.00 → $52.00Buy
    Rosenblatt
    DoorDash Inc.
    $DASH
    1/14/2026$280.00Outperform
    BNP Paribas Exane
    IREN Limited
    $IREN
    1/13/2026$80.00Sell → Buy
    H.C. Wainwright
    More analyst ratings

    $BLSH
    $DASH
    $FLY
    $IREN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $30,071 worth of shares (2,085 units at $14.42), increasing direct ownership by 0.77% to 272,214 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/9/26 7:31:19 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $50,038 worth of shares (3,171 units at $15.78), increasing direct ownership by 1% to 270,129 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/4/26 5:34:43 PM ET
    $WULF
    EDP Services
    Technology

    $BLSH
    $DASH
    $FLY
    $IREN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLSH
    $DASH
    $FLY
    $IREN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Newmont Corporation upgraded by Bernstein with a new price target

    Bernstein upgraded Newmont Corporation from Mkt Perform to Outperform and set a new price target of $157.00

    2/27/26 8:22:06 AM ET
    $NEM
    Precious Metals
    Basic Materials

    BMO Capital Markets reiterated coverage on Newmont Corporation with a new price target

    BMO Capital Markets reiterated coverage of Newmont Corporation with a rating of Outperform and set a new price target of $140.00 from $145.00 previously

    2/20/26 8:00:16 AM ET
    $NEM
    Precious Metals
    Basic Materials

    QuantumScape upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded QuantumScape from Reduce to Hold and set a new price target of $8.30

    2/19/26 7:48:39 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    $BLSH
    $DASH
    $FLY
    $IREN
    SEC Filings

    View All

    Firefly Aerospace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Firefly Aerospace Inc. (0001860160) (Filer)

    3/19/26 4:08:12 PM ET
    $FLY
    Military/Government/Technical
    Industrials

    TeraWulf Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure

    8-K - TERAWULF INC. (0001083301) (Filer)

    3/16/26 8:00:24 AM ET
    $WULF
    EDP Services
    Technology

    SEC Form 144 filed by QuantumScape Corporation

    144 - QuantumScape Corp (0001811414) (Subject)

    3/11/26 5:03:04 PM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    $BLSH
    $DASH
    $FLY
    $IREN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Firefly Aerospace Announces Fourth Quarter and Full Year 2025 Financial Results with Record Annual Revenue Up 163% Year-over-Year

    "Stairway to Seven" launching from Firefly's Space Launch Complex 2 at Vandenberg Space Force Base in California on March 11, 2026. CEDAR PARK, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- Firefly Aerospace (NASDAQ:FLY), a market leading space and defense technology company, today issued financial results for the fourth quarter and fiscal year ended December 31, 2025. "2025 was a transformative year in Firefly's history, as we more than doubled our annual revenue while executing across multiple launch, spacecraft, and ground programs and strengthening our portfolio of space exploration and national security space capabilities," said Jason Kim, CEO of Firefly Aerospace. "Our laser focus o

    3/19/26 4:10:00 PM ET
    $FLY
    Military/Government/Technical
    Industrials

    97% Recovery. Fully Permitted. 12 Kilometers From a 20-Million-Ounce Deposit. And Nobody's Talking About It.

    Issued on behalf of Lake Victoria Gold Ltd.VANCOUVER, BC, March 19, 2026 /CNW/ -- USANewsGroup.com -- There is a fully permitted gold project in Tanzania, sitting 12 kilometers from one of the largest gold mines on the African continent, where metallurgical testwork just confirmed that approximately 97% of the gold in the ground can be recovered using conventional processing. The company that owns it has Barrick Gold on its share register. It has Tanzania's most powerful mining billionaire as its strategic partner. Insiders hold over 70% of the float. And the stock trades below where Barrick bought in.If that sounds like the kind of setup that shouldn't exist in a market where gold is above

    3/19/26 10:00:00 AM ET
    $AEM
    $AU
    $B
    Precious Metals
    Basic Materials

    DoorDash Teams Up with Foot Locker, Kids Foot Locker, and Champs Sports for On-Demand Retail Delivery

    New partnership offers consumers seamless, on-demand delivery of the latest footwear styles, apparel and accessoriesNEW YORK, March 19, 2026 /PRNewswire/ -- DoorDash and Foot Locker today announced a new retail partnership, bringing leading athletic footwear and apparel brands — Foot Locker, Kids Foot Locker, and Champs Sports — to the DoorDash Marketplace. Through this partnership, consumers can now shop a wide assortment of sneakers, apparel, and accessories for on-demand delivery directly through DoorDash. With nearly 1,300 locations across Foot Locker, Kids Foot Locker, and

    3/19/26 9:00:00 AM ET
    $DASH
    EDP Services
    Technology

    $BLSH
    $DASH
    $FLY
    $IREN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bucella Michael C.

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/19/26 9:23:56 PM ET
    $WULF
    EDP Services
    Technology

    SEC Form 4 filed by Fleury Patrick

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/19/26 9:21:23 PM ET
    $WULF
    EDP Services
    Technology

    SEC Form 3 filed by new insider Yuan Kokuei

    3 - Bullish (0001872195) (Issuer)

    3/18/26 9:18:23 PM ET
    $BLSH
    Finance: Consumer Services
    Finance

    $BLSH
    $DASH
    $FLY
    $IREN
    Leadership Updates

    Live Leadership Updates

    View All

    QuantumScape Appoints Defense Executive Ross Niebergall to Board of Directors

    QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced the appointment of Ross Niebergall to its board of directors. Niebergall is an experienced executive with decades of service in the defense sector, leading R&D and technology commercialization in defense applications for multiple defense primes. Niebergall was most recently President of Aerojet Rocketdyne after its acquisition by L3Harris. He was Chief Technology Officer of L3Harris and Harris Corporation from 2017 to 2023. Previous to Harris Corporation, he was Vice President, Engineering at Raytheon and served as CEO of ThalesRaytheon Systems LLC, a join

    3/5/26 9:00:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    IREN Appoints John Gross as Chief Innovation Officer

    NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced the appointment of John Gross as Chief Innovation Officer, a newly established role responsible for leading engineering standards, thermal architecture, and commissioning across IREN's next-generation data centers. Mr. Gross is a globally recognized leader in data center engineering, with two decades of industry experience and deep expertise in high-density and liquid-cooled data center design. He serves as Vice Chair of committees within ASHRAE (American Society of Heating, Refrigerating and Air-Conditioning Engineers), which develops global standards for high-density and liquid-cooled data ce

    2/17/26 5:00:50 AM ET
    $IREN
    EDP Services
    Technology

    QuantumScape Welcomes Tech Industry Veteran Geoff Ribar to Board of Directors

    QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced the appointment of Geoff Ribar to its board of directors. Ribar brings deep expertise and extensive leadership experience in the technology industry, with decades serving as CFO for companies across the sector. Ribar was Chief Financial Officer at Cadence Design Systems from 2010 to 2017 and previously served as CFO at Telegent Systems, Matrix Semiconductor and NVIDIA Corporation, among others. He was formerly Vice President and corporate controller at Advanced Micro Devices (AMD). He also serves on the board of directors at Acacia Research Corporation, Ev

    1/30/26 6:55:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    $BLSH
    $DASH
    $FLY
    $IREN
    Financials

    Live finance-specific insights

    View All

    Firefly Aerospace to Announce Fourth Quarter 2025 Financial Results on March 19, 2026

    CEDAR PARK, Texas, March 12, 2026 (GLOBE NEWSWIRE) -- Firefly Aerospace (NASDAQ:FLY), a market leading space and defense technology company, today announced it will release its fourth quarter 2025 financial results for the period ended December 31, 2025, on Thursday, March 19, 2026, after market close. Firefly will hold a conference call the same day at 4:00 p.m. CT / 5:00 p.m. ET. A live webcast of the call and a replay will be available in the Investors section of the Company's website at https://investors.fireflyspace.com. The financial results news release will be posted in the Investors section of the Company's website under the "News" section. Additional materials supporting the c

    3/12/26 7:00:00 PM ET
    $FLY
    Military/Government/Technical
    Industrials

    TeraWulf Reports Fourth Quarter and Full Year 2025 Results

    Contracted 522 critical IT MW totaling over $12.8 billion1 of revenue Secured full funding for contracted capacity with construction advancing in alignment with tenant deployment timelines Multi-year development pipeline enables targeted annual delivery of 250 - 500 critical IT MW through the end of the decade EASTON, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (NASDAQ:WULF) ("TeraWulf" or the "Company"), an owner, developer, and operator of energy-advantaged digital infrastructure purpose-built for high-performance computing ("HPC") and artificial intelligence ("AI"), today announced its financial and operational results for the fourth quarter and full year ended December 31,

    2/26/26 4:05:00 PM ET
    $WULF
    EDP Services
    Technology

    Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments

    Net product revenues for the full year 2025 totaled $1,864.3 million, consisting of $965.6 million of PMO net product revenue and $898.7 million of ELEVIDYS net product revenue Net product revenues for the fourth quarter 2025 totaled $369.6 million, consisting of $259.2 million of PMO net product revenue and $110.4 million of ELEVIDYS net product revenue Following refinancing of 2027 notes and corporate restructuring, overall financial position and capital structure strengthened to support full investment in our pipeline and marketed therapies Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for

    2/25/26 4:05:00 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLSH
    $DASH
    $FLY
    $IREN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sarepta Therapeutics Inc.

    SC 13G/A - Sarepta Therapeutics, Inc. (0000873303) (Subject)

    11/13/24 10:27:59 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by TeraWulf Inc.

    SC 13G/A - TERAWULF INC. (0001083301) (Subject)

    11/12/24 5:47:40 PM ET
    $WULF
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Newmont Corporation

    SC 13G/A - NEWMONT Corp /DE/ (0001164727) (Subject)

    11/12/24 4:43:51 PM ET
    $NEM
    Precious Metals
    Basic Materials